Key enzyme missing from aggressive form of breast cancer, groundbreaking study shows
Thursday, February 28, 2013 - 21:00
in Health & Medicine
A groundbreaking new study has found that triple-negative breast cancer cells are missing a key enzyme that other cancer cells contain — providing insight into potential therapeutic targets to treat the aggressive cancer. The study is unique in that his lab is the only one in the country to specifically study the metabolic process of triple-negative breast cancer cells.